The global non-corticosteroid anti-inflammatory eyedrops market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 1.2 billion by 2030. The market is driven by factors such as increasing prevalence of ocular inflammation and rising demand for non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of ocular inflammation. Non-steroidal anti-inflammatory drugs are used in the treatment of various eye conditions such as allergic conjunctivitis, vernal keratoconjunctivitis, and dry eye syndrome. These drugs are also used in the management of postoperative pain following cataract surgery or corneal refractive surgery procedures. Non-steroidal anti inflammatory eyedrops are available in different formulations such as Ocufen, Mugabe, Diclofenac and others which have been approved by FDA for use in adults and children with ocular inflammation symptoms.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of allergic conjunctivitis and dry eye syndrome is expected to drive the demand for non-corticosteroid anti-inflammatory eyedrops.
- The increasing number of people suffering from chronic eye diseases such as glaucoma, cataract, and age-related macular degeneration is also expected to drive the demand for non-corticosteroid anti-inflammatory eyedrops.
- The growing awareness about the side effects associated with corticosteroids is also expected to fuel the growth of this market in near future.
- Increasing incidence rates of ocular surface disorders such as dry eye syndrome and allergic conjunctivitis are anticipated to boost the demand for non-corticosteroid anti inflammatory eyedrops.
- Increasing geriatric population base coupled with rising incidence rates of chronic eye diseases are anticipated to fuel the growth of this market.
Industry Growth Insights published a new data on “Non Corticosteroid Anti-inflammatory Eyedrops Market”. The research report is titled “Non Corticosteroid Anti-inflammatory Eyedrops Market research by Types (Ocufen, Mugabe, Diclofenac, Others), By Applications (Adult, Children), By Players/Companies Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon, Viva Opti-Free, Bausch & Lomb, Systane, Rite Aid, Walgreens, Staples, Clear eyes”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Non Corticosteroid Anti-inflammatory Eyedrops Market Research Report
By Type
Ocufen, Mugabe, Diclofenac, Others
By Application
Adult, Children
By Companies
Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon, Viva Opti-Free, Bausch & Lomb, Systane, Rite Aid, Walgreens, Staples, Clear eyes
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Non Corticosteroid Anti-inflammatory Eyedrops Market Report Segments:
The global Non Corticosteroid Anti-inflammatory Eyedrops market is segmented on the basis of:
Types
Ocufen, Mugabe, Diclofenac, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis AG
- Allergan, Inc.
- Meda Pharmaceuticals Inc
- Bausch & Lomb Inc
- Cigna
- Similasan Corporation
- Visine
- Alcon
- Viva Opti-Free
- Bausch & Lomb
- Systane
- Rite Aid
- Walgreens
- Staples
- Clear eyes
Highlights of The Non Corticosteroid Anti-inflammatory Eyedrops Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ocufen
- Mugabe
- Diclofenac
- Others
- By Application:
- Adult
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non Corticosteroid Anti-inflammatory Eyedrops Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Non corticosteroid anti-inflammatory eyedrops are a type of medication used to treat inflammation in the eyes. These drops contain a medicine that works by reducing the amount of inflammation in the eye.
Some of the key players operating in the non corticosteroid anti-inflammatory eyedrops market are Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon, Viva Opti-Free, Bausch & Lomb, Systane, Rite Aid, Walgreens, Staples, Clear eyes.
The non corticosteroid anti-inflammatory eyedrops market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Non Corticosteroid Anti-inflammatory Eyedrops Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Non Corticosteroid Anti-inflammatory Eyedrops Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Non Corticosteroid Anti-inflammatory Eyedrops Market - Supply Chain
4.5. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Forecast
4.5.1. Non Corticosteroid Anti-inflammatory Eyedrops Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Non Corticosteroid Anti-inflammatory Eyedrops Market Size (000 Units) and Y-o-Y Growth
4.5.3. Non Corticosteroid Anti-inflammatory Eyedrops Market Absolute $ Opportunity
5. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Type
5.3.1. Ocufen
5.3.2. Mugabe
5.3.3. Diclofenac
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Application
6.3.1. Adult
6.3.2. Children
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Non Corticosteroid Anti-inflammatory Eyedrops Demand Share Forecast, 2019-2029
9. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Application
9.4.1. Adult
9.4.2. Children
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Type
9.7.1. Ocufen
9.7.2. Mugabe
9.7.3. Diclofenac
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Non Corticosteroid Anti-inflammatory Eyedrops Demand Share Forecast, 2019-2029
10. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Application
10.4.1. Adult
10.4.2. Children
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Type
10.7.1. Ocufen
10.7.2. Mugabe
10.7.3. Diclofenac
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Demand Share Forecast, 2019-2029
11. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Application
11.4.1. Adult
11.4.2. Children
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Type 11.7.1. Ocufen
11.7.2. Mugabe
11.7.3. Diclofenac
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Non Corticosteroid Anti-inflammatory Eyedrops Demand Share, 2019-2029
12. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Application
12.4.1. Adult
12.4.2. Children
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Type
12.7.1. Ocufen
12.7.2. Mugabe
12.7.3. Diclofenac
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Non Corticosteroid Anti-inflammatory Eyedrops Demand Share, 2019-2029
13. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Application
13.4.1. Adult
13.4.2. Children
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size and Volume Forecast by Type
13.7.1. Ocufen
13.7.2. Mugabe
13.7.3. Diclofenac
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Non Corticosteroid Anti-inflammatory Eyedrops Market: Market Share Analysis
14.2. Non Corticosteroid Anti-inflammatory Eyedrops Distributors and Customers
14.3. Non Corticosteroid Anti-inflammatory Eyedrops Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Novartis AG
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Allergan, Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Meda Pharmaceuticals Inc
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bausch & Lomb Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cigna
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Similasan Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Visine
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Alcon
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Viva Opti-Free
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bausch & Lomb
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Systane
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Rite Aid
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Walgreens
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Staples
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Clear eyes
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook